Horizon Kinetics Medical ETF Rating $28.56 +0.19 (+0.67%) As of 03:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsRatingsTrendsBuy This Stock Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.MEDX Aggregate RatingModerate Buy 2.64Holdings in MEDX have an aggregate rating of Moderate Buy based on 348 analyst ratings issued in the past year covering 23 companies (81.1% of the portfolio).MEDX Aggregate Price Target$28.56High Prediction$28.56Average Prediction$28.56Low Prediction$28.56Holdings in MEDX have an aggregate price target of $28.56 and a range of $28.56 to $28.56 covering 23 companies (81.1% of the portfolio).MEDX Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy12 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Horizon Kinetics Medical ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 23 MEDX Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings13.29%LLYEli Lilly and Company$730.64+5.1%4.9985 of 5 stars2.65$950.17 30.0%23Trending NewsGap Up9.43%ABBVAbbVie$208.05+0.2%4.7446 of 5 stars2.96$214.95 3.3%27Trending NewsAnalyst Forecast6.66%ALNYAlnylam Pharmaceuticals$450.23+1.5%4.1233 of 5 stars2.85$405.33 -10.0%265.28%AZNAstraZeneca$79.95+0.4%2.7842 of 5 stars2.80$86.00 7.6%5Positive News5.09%JNJJohnson & Johnson$176.58-1.0%4.8711 of 5 stars2.65$176.29 -0.2%20Trending NewsOptions Volume4.69%BMYBristol Myers Squibb$47.11-0.1%4.8047 of 5 stars2.24$56.38 19.7%214.15%AMGNAmgen$289.14+0.2%4.7301 of 5 stars2.33$304.43 5.3%21Trending NewsAnalyst Forecast3.88%PFEPfizer$24.97-0.7%4.8749 of 5 stars2.39$28.12 12.6%18Positive News3.78%ALKSAlkermes$28.91-0.3%4.66 of 5 stars2.83$41.08 42.1%123.65%CRSPCRISPR Therapeutics$54.74+1.1%3.6424 of 5 stars2.50$71.60 30.8%163.33%MRKMerck & Co., Inc.$85.08-0.3%4.997 of 5 stars2.35$107.44 26.3%20Positive News3.16%IONSIonis Pharmaceuticals$42.04+0.5%4.5464 of 5 stars2.86$59.64 41.9%14Analyst ForecastAnalyst Revision2.61%GSKGSK$39.85+0.5%2.6213 of 5 stars1.88$37.38 -6.2%82.49%REGNRegeneron Pharmaceuticals$583.95+2.0%4.8493 of 5 stars2.81$829.65 42.1%26Positive News2.46%BIIBBiogen$136.17-0.1%4.835 of 5 stars2.34$185.74 36.4%32Trending News1.27%GALTGalectin Therapeutics$4.10+2.5%2.2275 of 5 stars3.00$6.00 46.3%11.06%BEAMBeam Therapeutics$16.55+0.7%2.2117 of 5 stars3.07$48.45 192.8%141.02%NTLAIntellia Therapeutics$11.380.0%4.5967 of 5 stars2.58$29.05 155.4%190.89%LTRNLantern Pharma$4.38-4.1%2.4495 of 5 stars3.00$25.00 470.3%10.82%HLNHaleon$9.64-0.5%4.3151 of 5 stars2.78$12.33 27.9%9News CoveragePositive News0.74%SDZNYSandoz Group$62.12-0.9%1.4928 of 5 stars2.0030.67%VNDAVanda Pharmaceuticals$4.66+1.0%4.311 of 5 stars3.50$16.50 254.5%20.66%BCYCBicycle Therapeutics$6.98-2.0%3.2756 of 5 stars2.70$22.22 218.6%10 This page (NASDAQ:MEDX) was last updated on 8/26/2025 by MarketBeat.com Staff From Our Partners“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredWhat Steve Bannon revealed about Trump’s gold playA Trump advisor just said 3 words that could reset the dollar. It’s a gold move nobody saw coming—and your ...Reagan Gold Group | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 30th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Horizon Kinetics Medical ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Horizon Kinetics Medical ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access